Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

SB Dreyer, NB Jamieson, L Evers, F Duthie… - Chinese Clinical …, 2019 - eprints.gla.ac.uk
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers, F Duthie, S Cooke… - 2019 - hero.epa.gov
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

[HTML][HTML] Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers… - Chinese Clinical …, 2019 - cco.amegroups.org
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

[PDF][PDF] Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers, F Duthie, S Cooke… - 2019 - cdn.amegroups.cn
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers… - Chinese clinical …, 2019 - pubmed.ncbi.nlm.nih.gov
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

SB Dreyer, NB Jamieson, L Evers, F Duthie… - Chinese Clinical …, 2019 - europepmc.org
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

[引用][C] Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers, F Duthie… - Chinese Clinical …, 2019 - cir.nii.ac.jp
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer
for next-generation molecular profiling | CiNii Research CiNii 国立情報学研究所 学術情報 …

[PDF][PDF] Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers, F Duthie, S Cooke… - 2019 - core.ac.uk
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling.

SB Dreyer, NB Jamieson, L Evers, F Duthie… - Chinese Clinical …, 2019 - europepmc.org
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …

Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profiling

SB Dreyer, NB Jamieson, L Evers… - Chinese Clinical …, 2019 - cco.amegroups.org
Next-generation sequencing is enabling molecularly guided therapy for many cancer types,
yet failure rates remain relatively high in pancreatic cancer (PC). The aim of this study is to …